Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / NOTE 2.500% 1/1
-
Market price (% of par)
-
130.33%
-
Total 13F principal
-
$376,578,000
-
Principal change
-
-$23,454,012
-
Total reported market value
-
$517,601,664
-
Number of holders
-
40
-
Value change
-
-$11,399,808
-
Number of buys
-
18
-
Number of sells
-
15
Institutional Holders of MEDICINES CO - NOTE 2.500% 1/1 as of Q2 2017
As of 30 Jun 2017,
MEDICINES CO - NOTE 2.500% 1/1 was held by
40 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$376,578,000
in principal (par value) of the bond.
The largest 10 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, CNH PARTNERS LLC, UBS ASSET MANAGEMENT AMERICAS INC, LINDEN ADVISORS LP, CAPSTONE INVESTMENT ADVISORS, LLC, DEUTSCHE BANK AG\, WELLS FARGO & COMPANY/MN, LAZARD ASSET MANAGEMENT LLC, Myriad Asset Management Ltd., and Allianz Asset Management GmbH.
This page lists
40
institutional bondholders reporting positions
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.